Ward Zoe, Ridgewell Emily, Quigley Matthew, Fatone Stefania, Dillon Michael P
Department of Physiotherapy, Podiatry and Prosthetics and Orthotics, La Trobe University, Melbourne, Australia.
Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
Disabil Rehabil. 2025 Feb;47(3):549-559. doi: 10.1080/09638288.2024.2355988. Epub 2024 May 22.
A large proportion of people die in the years following dysvascular partial foot amputation (PFA) or transtibial amputation (TTA) given the long-term consequences of peripheral vascular disease and/or diabetes. A critical appraisal of recent research is needed to understand the underlying cause of variation and synthesise data for use in consultations about amputation surgery and patient-facing resources. This systematic review aimed to describe proportionate mortality following dysvascular PFA and to compare this between PFA and TTA.
The review protocol was registered in PROSPERO (CRD42023399161). Peer-reviewed studies of original research were included if they: were published in English between 1 January 2016, and 12 April 2024, included discrete cohorts with PFA, or PFA and TTA, and measured proportionate mortality following dysvascular amputation.
Seventeen studies were included in the review. Following dysvascular PFA, proportionate mortality increased from 30 days (2.1%) to 1-year (13.9%), 3-years (30.1%), and 5-years (42.2%). One study compared proportionate mortality 1-year after dysvascular PFA and TTA, showing a higher relative risk of dying after TTA (RR 1.51).
Proportionate mortality has not changed in recent years. These results are comparable to a previous systematic review that included studies published before 31 December 2015.Implications for rehabilitationIt is important to ensure data describing mortality in the years following dysvascular partial foot or transtibial amputation is up to date and accurate.Evidence about proportionate mortality has not changed in recent years and the results are comparable to previous systematic reviews.Data describing mortality outcomes can be used in decision aids that support conversations about the choice of amputation level.
鉴于外周血管疾病和/或糖尿病的长期后果,很大一部分人在血管性部分足部截肢(PFA)或经胫骨截肢(TTA)后的几年内死亡。需要对近期研究进行批判性评估,以了解差异的潜在原因,并综合数据用于截肢手术咨询和面向患者的资源。本系统评价旨在描述血管性PFA后的比例死亡率,并比较PFA和TTA之间的这一指标。
该评价方案已在国际前瞻性系统评价注册库(PROSPERO,注册号:CRD42023399161)登记。纳入的原始研究的同行评审研究需满足以下条件:于2016年1月1日至2024年4月12日期间以英文发表;纳入了患有PFA或同时患有PFA和TTA的离散队列,并测量了血管性截肢后的比例死亡率。
本评价纳入了17项研究。血管性PFA后,比例死亡率从30天(2.1%)增加到1年(13.9%)、3年(30.1%)和5年(42.2%)。一项研究比较了血管性PFA和TTA后1年的比例死亡率,结果显示TTA后死亡的相对风险更高(风险比1.51)。
近年来比例死亡率没有变化。这些结果与之前一项纳入2015年12月31日前发表研究的系统评价结果相当。
对康复的启示
确保描述血管性部分足部或经胫骨截肢后数年死亡率的数据是最新且准确的,这一点很重要。
近年来关于比例死亡率的证据没有变化,结果与之前的系统评价相当。
描述死亡率结果的数据可用于辅助决策,支持有关截肢水平选择的讨论。